News
India has proposed increasing US manufacturing by Indian pharma providers of APIs and the final stages of drug processing ...
Orion Corporation has broadened its partnership with Glykos, focusing on the development of antibody-drug conjugates (ADCs).
The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.
Novo Nordisk is looking to partner with digital companies at every stage of the weight loss journey to help patients lose ...
Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...
Lisata Therapeutics has formed a strategic partnership with GATC Health for advancing AI-driven drug discovery and ...
The test is currently available in private healthcare facilities but there are hopes it may be adopted by the NHS.
The European Commission (EC) has granted marketing authorisation for Averoa's oral therapy Xoanacyl for chronic kidney ...
European companies must be able to provide developed and scalable business models if they want to enter the US to manage the ...
Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient ...
European biotechs have historically struggled to find capital on the continent, but the funding ecosystem now aims to scale ...
NextCure has entered a strategic partnership with Simcere Zaiming, to develop SIM0505, a new ADC targeting CDH6 for treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results